Bănică D, Algeorge G, Moisoiu A, Petre A, Toancă M
Laboratorul de imunomicrobiologie, Institutul de Pneumoftiziologie Marius Nasta, Bucureşti.
Pneumoftiziologia. 1994 Jul-Dec;43(3-4):173-7.
The study concerns 264 cases among which: 119 active lung tb. eliminating and 11 cases not-eliminating M. Tuberculosis; 17 cases of extrarespiratory tb. confirmed by bacteriology and/or by anatomopathology; 18 cases of bone-joint non-tb disease; 38 cases of chronic lung disease other than tb; 61 healthy persons (controls). Sera from these cases were collected before treatment and submitted concomitantly to two different methods: (1) Mycodot test (immunoblot) with lipoarabinomannan (LAM) as antigen, on nitrocellulose discs (Dynagen, Cambridge, MA, USA); (2) ELISA test with antigen 60 (A60) (ANDA-Biologicals, Strasbourg, France) and with antigen I.C. (Cantacuzino Institute, Bucharest). The results were estimated on terms of sensitivity and specificity. As for sensitivity the results show 74-90%. the highest values were reached in ELISA with A60 IgA. The specificity of the Mycodot test was highest: 90-100% in the two successive experiments. The active tb diagnosis discrimination capacity of the studied methods allows the following classification: 1. Mycodot test with LAM antigen 2. ELISA with A60-Ig G complex 3. ELISA with I.C. antigen The Mycodot test is more advantageous being more rapid and more simple to perform.
该研究涉及264例病例,其中:119例活动性肺结核正在治愈,11例未清除结核分枝杆菌;17例肺外结核经细菌学和/或解剖病理学确诊;18例骨关节非结核疾病;38例除结核外的慢性肺病;61例健康人(对照)。在治疗前收集这些病例的血清,并同时采用两种不同方法:(1)以脂阿拉伯甘露聚糖(LAM)为抗原的Mycodot试验(免疫印迹法),在硝酸纤维素膜片(美国马萨诸塞州剑桥市Dynagen公司)上进行;(2)采用抗原60(A60)(法国斯特拉斯堡ANDA生物制品公司)和抗原I.C.(罗马尼亚布加勒斯特坎塔库齐诺研究所)的ELISA试验。根据敏感性和特异性对结果进行评估。就敏感性而言,结果显示为74% - 90%。在采用A60 IgA的ELISA试验中达到最高值。Mycodot试验的特异性最高:在两次连续实验中为90% - 100%。所研究方法对活动性结核的诊断鉴别能力可进行如下分类:1. 采用LAM抗原的Mycodot试验;2. 采用A60 - Ig G复合物的ELISA试验;3. 采用I.C.抗原的ELISA试验。Mycodot试验更具优势,因为其操作更快速、更简便。